Share This Page
Drug Price Trends for OPILL
✉ Email this page to a colleague
Average Pharmacy Cost for OPILL
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| OPILL 0.075 MG TABLET | 00113-8101-04 | 0.55112 | EACH | 2025-04-23 |
| OPILL 0.075 MG TABLET | 00113-8101-01 | 0.55112 | EACH | 2025-04-23 |
| OPILL 0.075 MG TABLET | 00113-8101-06 | 0.55112 | EACH | 2025-04-23 |
| OPILL 0.075 MG TABLET | 00113-8101-03 | 0.55112 | EACH | 2025-04-23 |
| OPILL 0.075 MG TABLET | 00113-8101-01 | 0.55086 | EACH | 2025-03-19 |
| OPILL 0.075 MG TABLET | 00113-8101-03 | 0.55086 | EACH | 2025-03-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for Opill: The First OTC Birth Control Pill in the U.S.
Introduction to Opill
Opill, the first over-the-counter (OTC) birth control pill approved in the U.S., has begun shipping to thousands of retail stores and pharmacies nationwide. This development marks a significant shift in the contraception market, offering consumers a new level of accessibility and convenience.
Market Context: The U.S. Contraception Market
The U.S. contraception market is substantial, with oral birth control pills representing 37% of the $8 billion contraceptive market. The prescription birth control pill market alone is estimated to be worth about $3 billion annually[1].
FDA Approval and Launch
Opill was approved by the FDA in July 2023 for OTC sales, and Perrigo, the manufacturer, has started shipping the product to major retailers and pharmacies. This launch is significant as it eliminates the need for a prescription, potentially increasing the utilization of oral contraception[2].
Pricing and Affordability
The suggested retail price for Opill is $19.99 for a one-month supply, $49.99 for a three-month supply, and $89.99 for a six-month supply. These prices may pose a barrier for some Americans, as no commercial insurer currently covers Opill unless legally required to do so. Only eight states have statutory mandates requiring insurance companies to cover OTC contraception, and Wisconsin has announced coverage through its Medicaid programs[1][5].
Consumer Willingness to Pay
Research indicates that many women who are likely to use an OTC oral contraceptive pill may not be willing or able to pay the suggested retail price. For instance, 39% of potential users would be willing to pay only $1-$10 per month, and 11% would not be willing to pay anything at all[5].
Impact on Prescription Contraceptives
The introduction of Opill could potentially siphon sales away from prescription contraceptives, but the extent of this impact is unclear. Historically, therapeutic classes have transitioned from prescription-only to majority-OTC within a decade. For example, it took about four years for OTC to dominate the non-drowsy oral antihistamine market and more than six years for steroid-based nasal allergy sprays[1].
Effect on Utilization
David Spangler from the Consumer Healthcare Products Association (CHPA) noted that OTC conversions have boosted overall usage in other therapeutic classes by eliminating the need for a prescription and the associated costs and discomfort. However, the speed of this transition for birth control pills is uncertain due to the specific molecule involved[1].
Coverage and Insurance
Federal policy does not require private health insurance plans or Medicaid expansion programs to cover nonprescription contraception. However, seven states require state-regulated private health insurance plans to cover at least some methods of OTC contraception without cost-sharing, and seven states use state funds to offer similar coverage for Medicaid enrollees[5].
State-Level Initiatives
States like Wisconsin have taken steps to cover Opill through their Medicaid programs, but the majority of private health insurance plans are subject only to federal laws, limiting the reach of these state-level initiatives[1][5].
Effectiveness and Safety
Opill, which contains only norgestrel (a progestin) and no estrogen, is 98% effective when taken as directed, making it the most effective OTC birth control method available. This formulation generally carries fewer side effects compared to combination estrogen and progestin pills[2][4].
Consumer Convenience
The availability of Opill in stores and online is expected to reduce the share of women who miss taking their contraception on time due to difficulties in maintaining a continuous supply. Traditionally, patients had to obtain a prescription and then pick up their supply at a pharmacy, which could lead to gaps in usage[5].
Price Comparisons and Global Context
Prescription drug prices in the U.S. are significantly higher than in other countries, with U.S. prices averaging 2.78 times those in 33 other nations. This disparity is even more pronounced for brand-name drugs, which are 4.22 times more expensive in the U.S. compared to other countries[3].
Implications for Opill Pricing
Given the high cost of prescription drugs in the U.S., the OTC pricing of Opill, although relatively affordable compared to some prescription options, still presents a financial barrier for many consumers. The lack of insurance coverage exacerbates this issue[1][3].
Future of the Birth Control Pill Market
The introduction of Opill represents a new horizon for reproductive health access, but its long-term impact on the market remains to be seen. Fady Boctor, CEO of Petros Pharmaceuticals, noted that it will be interesting to observe how OTC access increases the utilization of oral contraception[1].
Potential Market Shifts
Historical data suggests that therapeutic classes can transition from prescription-only to majority-OTC within a decade. However, the speed and extent of this transition for birth control pills will depend on various factors, including consumer acceptance, pricing, and insurance coverage[1].
Key Takeaways
- Market Size: The U.S. prescription birth control pill market is estimated to be worth about $3 billion annually.
- Pricing: Opill is priced at $19.99 for a one-month supply, $49.99 for three months, and $89.99 for six months.
- Coverage: No federal requirement for insurance coverage of OTC contraception; only eight states and Wisconsin's Medicaid programs provide coverage.
- Effectiveness: Opill is 98% effective when taken as directed.
- Consumer Convenience: Reduces gaps in usage by eliminating the need for a prescription.
- Global Context: U.S. prescription drug prices are significantly higher than in other countries.
FAQs
Q: What is the suggested retail price for Opill?
A: The suggested retail price for Opill is $19.99 for a one-month supply, $49.99 for a three-month supply, and $89.99 for a six-month supply[1][4].
Q: Is Opill covered by insurance?
A: No, Opill is not covered by commercial insurers unless legally required. Only eight states and Wisconsin's Medicaid programs provide coverage[1][5].
Q: How effective is Opill?
A: Opill is 98% effective when taken as directed[4].
Q: What are the potential barriers to Opill adoption?
A: Price and lack of insurance coverage are significant barriers. Many potential users are not willing or able to pay the suggested retail price[5].
Q: How does Opill compare to other birth control methods?
A: Opill contains only norgestrel (a progestin) and no estrogen, generally carrying fewer side effects than combination pills. It is the most effective OTC birth control method available[2][4].
Sources
- BioSpace: "Birth Control Market Evolves as OTC Opill Hits US Stores"
- PBS NewsHour: "First over-the-counter birth control pill in U.S. begins shipping to stores"
- RAND: "Prescription Drug Prices in the U.S. Are 2.78 Times Those in Other Countries"
- PR Newswire: "Perrigo Commences Shipments of Opill® to Retailers Nationwide"
- KFF: "3 Charts: The Cost and Coverage of Opill—the First FDA-approved OTC Daily Oral Contraceptive Pill in the United States"
More… ↓
